The Business Times
business-time-50
SUBSCRIBERS

HK firm exits Biosensors for US$312.3m

google-preferred-sourceAdd BT as a preferred source
Published Fri, Nov 22, 2013 · 10:00 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Singapore

SHANDONG Weigao will be selling its entire 21.7 per cent stake in Singapore medical devices firm Biosensors International Group for US$312.3 million, because of increasing competition in China and its intention to focus on its main businesses.

Shandong Weigao, via its wholly owned subsidiary, Wellford Capital, will sell its stake to Bermuda's CB Medical Holdings at S$1.05 per share, which represents a premium of around 11.7 per cent to Biosensors' closing price of S$0.94 on Thursday.

Copyright SPH Media. All rights reserved.

Reuse this contentFeedback

TRENDING NOW

With the move, Ensign InfoSecurity will be reclassified as an associated company of StarHub, rather than a subsidiary.

StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain

The yen weakened to a low of 125.33 yen per Singdollar on April 13, before recovering slightly to about 124.91 on April 15.

Singaporeans can now buy record amount of yen per Singdollar

Air India has been one of the foreign carriers most affected by the outbreak of hostilities in the Middle East.

Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss

Keppel DC Singapore 7 and 8 (above). Portfolio occupancy of the Reit stands at 95.6%, with a reversion of about 51%.

Keppel DC Reit posts 13.2% higher Q1 DPU of S$0.02833 on strong portfolio performance

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More